Click to zoom
Product Description
Herti 440 mg is an injectable formulation of Trastuzumab, a targeted monoclonal antibody primarily used to treat HER2-positive breast and metastatic gastric cancers. It works by binding to HER2 proteins, thereby inhibiting cancer cell growth and promoting immune-mediated cell destruction.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Dosage Form Injection
Treatment Breast Cancer, Gastric Cancer, Metastatic Cancer, Esophageal Cancer, HER2-Positive Cancers
Packaging Type Vial
Brand Herti
Manufacturer Hetero Healthcare Limited
Strength 440 mg
Brand Name Herti
Manufactured By Hetro Healthcare
Country of Origin Made in India
Pack Size 1 injection in 1 vial
Minimum order quantity: 50 Piece
Shipping Information
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.
500 mg CIPRODAC 500 CIPROFLOXACIN IP TABLETS
On Request
500 mg Ciplox-500 Ciprofloxacin Hydrochloride IP Tablets
On Request
12 mg Iverheal 12 Ivermectin Dispersible Tablets
On Request
500 mg Novamox-500 Amoxycillin Trihydrate IP Capsules
On Request
500 mg Methoflam-500 Methocarbamol IP Tablets
On Request
25 mg Baclosign-25 Baclofen Tablets
On Request
25 mg LENANAMO Lenalidomide Capsules
On Request
500 mg Captomer MERCAPTOPURINE I.P. TABLETS
On Request